Advisor Group Holdings Reduces Investment in Chemed Corporation

June 3, 2023

🌥️Trending News

Chemed Corporation ($NYSE:CHE) is a leading provider of home health and hospice services. It operates through its two subsidiaries, VITAS Healthcare and Roto-Rooter, which provide home health care and plumbing services, respectively. Recently, Advisor Group Holdings Inc. has decreased its stake in Chemed Corporation’s shares. This sale could possibly be due to the decline of the company’s stock prices in the previous quarter. Chemed Corporation’s stock closed lower on the day of the announcement, but has since recovered some ground.

Despite the stock’s decline, Chemed Corporation has proved to be a reliable and long-term performer in its sector, with its subsidiaries performing well over a sustained period of time. This news of a reduced investment has not affected the company’s overall prospects and business strategy. Chemed Corporation remains a strong provider of home health and hospice services and has a bright future ahead. Investors should keep a close watch on this company’s performance and continue to remain invested in the long term as it is likely to pay off handsomely.

Price History

The news had an immediate impact on Chemed Corporation‘s stock price, which opened at $532.9 and closed at $542.7, up by 1.7% from the previous closing price of $533.4. The reduction in investment by Advisor Group Holdings Inc. caused some uncertainty among investors, causing the stock to fluctuate throughout the day. However, the closing price was still up from the opening price, indicating investor confidence in the future of Chemed Corporation. Live Quote…

About the Company

  • Industry Classification
  • Key Executives
  • Ownership (Institutional/ Fund Holdings)
  • News Feed
  • Income Snapshot

    Below shows the total revenue, net income and net margin for Chemed Corporation. More…

    Total Revenues Net Income Net Margin
    2.16k 239.58 11.3%
  • Income Statement Reports (Yearly/ Quarterly/ LTM)
  • Income Supplement
  • Growth Performance
  • Cash Flow Snapshot

    Below shows the cash from operations, investing and financing for Chemed Corporation. More…

    Operations Investing Financing
    269.29 -62.47 -166.93
  • Cash Flow Statement (Yearly/ Quarterly/ LTM)
  • Cash Flow Supplement
  • Balance Sheet Snapshot

    Below shows the total assets, liabilities and book value per share for Chemed Corporation. More…

    Total Assets Total Liabilities Book Value Per Share
    1.43k 551.13 58.66
  • Balance Sheet (Yearly/ Quarterly)
  • Balance Sheet Supplement
  • Key Ratios Snapshot

    Some of the financial key ratios for Chemed Corporation are shown below. More…

    3Y Rev Growth 3Y Operating Profit Growth Operating Margin
    2.8% 4.7% 14.9%
    FCF Margin ROE ROA
    9.6% 23.9% 14.0%
  • Income Statement Ratios
  • Balance Sheet Ratios
  • Cash Flow Ratios
  • Valuation Ratios
  • Other Ratios
  • Other Supplementary Items
  • Analysis

    At GoodWhale, we have analyzed the financials of CHEMED CORPORATION and have concluded that it is a medium risk investment in terms of financial and business aspects. Our Risk Rating helps to identify companies that are potentially risky investments. We have also detected three risk warnings in CHEMED CORPORATION’s income sheet, balance sheet, and non-financial aspects. If you become a registered user, you can view these risk warnings and make an informed decision on whether this company is a good investment for you. More…

  • Risk Rating Analysis
  • Star Chart Analysis
  • Valuation Analysis




  • Peers

    The competition between Chemed Corp and its competitors is fierce. Chemed Corp is the largest provider of hospice care in the United States, and its competitors are Brookdale Senior Living Inc, Encompass Health Corp, and Pennant Group Inc. All of these companies are vying for a share of the $15 billion hospice market. Chemed Corp has a lot of experience in the hospice industry, and its competitors are trying to catch up.

    – Brookdale Senior Living Inc ($NYSE:BKD)

    Brookdale Senior Living Inc is a company that owns and operates senior living communities. As of 2022, the company had a market cap of 837.09M and a ROE of 10.52%. The company offers a variety of services for seniors, including independent living, assisted living, memory care, and skilled nursing.

    – Encompass Health Corp ($NYSE:EHC)

    Encompass Health Corporation is a provider of rehabilitation and wellness services. The company operates through two segments: Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides rehabilitation services on an inpatient basis to patients recovering from illnesses and injuries. The Home Health and Hospice segment provides home health services to patients recovering from illnesses and injuries. Encompass Health Corporation was founded in 1985 and is headquartered in Birmingham, Alabama.

    – Pennant Group Inc ($NASDAQ:PNTG)

    The Pennant Group, Inc. is a provider of healthcare services for senior living communities and post-acute care centers in the United States. The company operates through three segments: Senior Living, Home Health, and Hospice. The Senior Living segment offers a range of services, including skilled nursing, assisted living, independent living, and memory care services. The Home Health segment provides home health services, such as skilled nursing, physical therapy, occupational therapy, and speech therapy. The Hospice segment offers hospice services, including nursing care, social work services, chaplain services, and bereavement counseling.

    Summary

    Chemed Corporation is a diversified company providing services in the fields of hospice and home health care, plumbing and drain cleaning, and specialty emergency services. Recent investing analysis suggests that Chemed is an attractive investment opportunity. Advisor Group Holdings Inc. recently cut its position in shares of Chemed Co, indicating a potential near-term share price decline. With a current market capitalization of nearly 4 billion dollars, Chemed is well established in the respective markets it serves.

    Chemed appears to have solid fundamentals, including a competitive balance sheet and strong cash flows. Analysts have also noted the company’s conservative debt levels and healthy dividend yield. Overall, Chemed’s financial performance is likely to remain strong in the near future, making it an attractive stock for investors looking for steady growth.

    Recent Posts

    Leave a Comment